Malibary Manal A
Department of Food and Nutrition, Faculty of Human Sciences and Design, King Abdulaziz University, Jeddah, Saudi Arabia.
PPAR Res. 2023 Feb 1;2023:7405954. doi: 10.1155/2023/7405954. eCollection 2023.
Inhibiting adipocyte differentiation, the conversion of preadipocytes to mature functional adipocytes, might represent a new approach to treating obesity and related metabolic disorders. Peroxisome proliferator-activated receptor and CCAAT-enhancer-binding protein are two master coregulators controlling adipogenesis both in culture and in vivo. Many recent studies have confirmed the relationship between retinoic acid (RA) and the conversion of embryonic stem cells into adipocytes; however, these studies have shown that RA potently blocks the differentiation of preadipocytes into mature adipocytes. Nevertheless, the functional role of RA in early tissue development and stem cell differentiation, including in adipose tissue, remains unclear. This study highlights transcription factors that block adipocyte differentiation and maintain preadipocyte status, focusing on those controlled by RA. However, some of these novel adipogenesis inhibitors have not been validated in vivo, and their mechanisms of action require further clarification.
抑制脂肪细胞分化,即前脂肪细胞向成熟功能性脂肪细胞的转化,可能代表一种治疗肥胖及相关代谢紊乱的新方法。过氧化物酶体增殖物激活受体和CCAAT增强子结合蛋白是在培养和体内控制脂肪生成的两个主要共调节因子。最近许多研究证实了视黄酸(RA)与胚胎干细胞向脂肪细胞转化之间的关系;然而,这些研究表明RA能有效阻断前脂肪细胞向成熟脂肪细胞的分化。尽管如此,RA在早期组织发育和干细胞分化(包括脂肪组织)中的功能作用仍不清楚。本研究重点关注受RA调控的、阻断脂肪细胞分化并维持前脂肪细胞状态的转录因子。然而,其中一些新型脂肪生成抑制剂尚未在体内得到验证,其作用机制需要进一步阐明。